Buckman from Viratech is CEOing Vantage now with Barbera running Nanobeak and MSGI. Clinic trials to start in August. Just wait until one of the major pharmaceuticals bring these things to market
http://finance.yahoo.com/news/dr-kevin-buckma...00998.html